Literature DB >> 12798520

Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.

Jarosław Daniloś1, Andrzej Goral, Piotr Paluszkiewicz, Krzysztof Przesmycki, Jan Kotarski.   

Abstract

BACKGROUND: Postoperative bleeding may be complicated by failure to identify the site of bleeding, multiple bleeding points, and persistent hemorrhage despite surgical intervention. CASE: Activated recombinant factor VII was used successfully in a patient with life-threatening postsurgical bleeding after resection of two large extraperitoneal pelvic sarcomas.
CONCLUSION: In severe hemorrhage, hemostasis can be achieved with activated recombinant factor VII.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12798520

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


  7 in total

1.  A simple technique of inserting an intra-abdominal drain in laparoscopic surgery.

Authors:  Vishwanath Golash
Journal:  Oman Med J       Date:  2009-01

2.  [Recombinant activated factor VIIa for treatment of traumatic liver rupture].

Authors:  W Leidinger; J N Meierhofer; R Woelfel
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

Review 3.  Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.

Authors:  R Michael Grounds; Charles Bolan
Journal:  Crit Care       Date:  2005-10-07       Impact factor: 9.097

4.  Spontaneous rupture of adrenal haemangioma mimicking abdominal aortic aneurysm rupture.

Authors:  Piotr Paluszkiewicz; Iwona Ambroziak; Katarzyna Hołyńska-Dąbrowska; Zofia Siezieniewska-Skowrońska; Andrzej Paluszkiewicz
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

5.  Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.

Authors:  Jean-Louis Vincent; Rolf Rossaint; Bruno Riou; Yves Ozier; David Zideman; Donat R Spahn
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Recombinant activated factor VIIa to treat refractory lower gastrointestinal hemorrhage in a patient with recently implanted mechanical valve: a case report.

Authors:  Amr S Omar; Suraj Sudarsanan; Hesham Ewila; Ali Kindawi
Journal:  BMC Res Notes       Date:  2014-08-15

Review 7.  Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data.

Authors:  Christian von Heymann; Sven Jonas; Claudia Spies; Klaus-Dieter Wernecke; Sabine Ziemer; Detlev Janssen; Jürgen Koscielny
Journal:  Crit Care       Date:  2008-02-15       Impact factor: 9.097
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.